Board-certified medical oncologist joins AON’s CCBD physician teamBETHESDA, Md., Oct. 07, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), today announced that medical oncologist Chitra Rajagopal, MD (“Dr. Raj”), has joined the physician care team. She will see patients in Germantown and Bethesda, Maryland, alongside the practice’s existing ...

COLUMBUS, Ohio, Sept. 09, 2025 (GLOBE NEWSWIRE) -- American Oncology Network, one of the nation’s fastest-growing networks of community-based oncology practices, announced today that Board-certified medical oncologist Taral Patel, MD, of AON partner practice Zangmeister Cancer Center, authored and presented research at the IASLC 2025 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer (#WCLC25) Sept. 6-9 in Barcelona, Spain. Dr. Patel’s study, Assessment of ...

Company Overview - American Oncology Network (AON) is a rapidly growing network of community-based oncology practices, representing over 300 providers across 20 states since its founding in 2018 [7] - Low Country Cancer Care (LCCC) specializes in the care of cancer and blood disorders, focusing on patient care, prevention, education, and research in Georgia and South Carolina [8] New Appointment - Dr. Anton Juncaj has joined the physician team at Low Country Cancer Care, enhancing the practice's capacity to provide high-quality cancer care [1][4] - Dr. Juncaj has extensive training in oncology and hematology, having completed his residency and fellowship at Ascension Genesys Hospital in Michigan [2] Team Expansion - The addition of Dr. Juncaj brings the total number of medical oncologists at LCCC to five, allowing for improved patient care through state-of-the-art technology and the latest clinical research [3] - The practice operates across five locations in Georgia and South Carolina, providing comprehensive cancer care services [3] Commitment to Care - LCCC emphasizes a patient-centered approach, combining innovative cancer care with evidence-based medicine and holistic practices [3] - AON's model promotes value-based care, aiming to improve patient outcomes while reducing costs and expanding access to quality care [7]

Company Overview - Genesis Cancer and Blood Institute is a recognized provider of expert cancer care in Arkansas, specializing in the diagnosis and treatment of cancer and hematology [8] - The institute has a team of highly trained physicians, clinicians, and staff dedicated to ensuring optimal patient outcomes [8] New Appointment - Dr. Beau Hilton has joined Genesis Cancer and Blood Institute as a medical oncologist, enhancing the physician care team [1][4] - Dr. Hilton earned his Doctor of Medicine from the Cleveland Clinic Lerner College of Medicine and completed his residency and fellowship at Vanderbilt University Medical Center [2] Team and Services - Genesis Cancer and Blood Institute comprises 11 medical oncologists and five advanced practice providers across 11 locations in Arkansas, offering comprehensive cancer services including diagnosis, treatment, clinical trials, survivorship, and patient support [3] - The practice is committed to providing personalized, patient-centered care in a community setting [2][3] Organizational Commitment - American Oncology Network (AON) supports Genesis Cancer and Blood Institute, focusing on the long-term success of community oncology and ensuring high-quality, community-based care [7] - AON's network includes over 300 providers across 20 states, promoting health equity and addressing disparities in cancer care [7]

Core Insights - American Oncology Network (AON) achieved annual revenue exceeding $2 billion for the 12 months ending June 30, 2025, reflecting over 40% growth compared to the previous year [1][2] - The provider network expanded to over 300 oncology and hematology specialists across 20 states, enhancing access to advanced treatments and diagnostics [2][4] Financial Performance - AON's revenue growth is attributed to both organic expansion and the addition of numerous practices and providers in new markets [2] - Partner practices experience an average increase of over 30% in sustainable income after joining AON [3] Network Expansion - AON added dozens of new practices and providers, continuing to grow its network [4] - The company is actively recruiting providers for 16 clinic locations and plans to welcome four new physicians next month [6] Treatment Innovations - More than 40 AON-affiliated clinics began offering bispecific T-cell engager (BiTE) therapies, expanding access to advanced immunotherapy [7] - AON broadened access to radioligand therapies (RLT) for certain metastatic and rare cancers [8] - AON launched a cloud-based laboratory information system to improve efficiency across its pathology and oncology labs [9] - AON co-created MiBA, an AI-enabled trial matching and patient navigation platform to enhance access to clinical trials [10] Value-Based Care Initiatives - AON achieved nearly $6 million in cost savings for CMS through the Enhancing Oncology Model (EOM) and partnered with a multi-state commercial value-based care organization, resulting in $2.7 million in cumulative savings [17] - AON implemented a social risk navigation platform, leading to a 39% improvement in social risk factors contributing to better health outcomes [17] Leadership and Vision - AON appointed several senior leaders in the first half of 2025 to support continued growth [13] - The company aims to amplify its national impact by advancing clinical innovation and strengthening partnerships [14] - AON is committed to ensuring personalized, high-quality care while reducing costs and improving outcomes [15]

Core Insights - Conway Hematology Oncology (CHO) has joined the American Oncology Network (AON), enhancing its ability to provide patient-focused services and expand clinical trial offerings [1][2][6] Company Overview - CHO has been a trusted provider of hematology and oncology care in Conway, Arkansas, since its founding in 1998 by Dr. Sue Tsuda [3][11] - The practice is recognized as the longest-running full-time cancer clinic in Faulkner County, Arkansas, and is dedicated to the physical and mental health of cancer patients and their families [11] Partnership Details - The partnership with AON allows CHO to broaden its services and bring advanced treatments to patients while maintaining high-quality, compassionate care [2][6] - AON is a rapidly expanding network representing over 300 providers across 20 states, focusing on community oncology and innovative healthcare solutions [10] Leadership and Expertise - Dr. Sue Tsuda, co-founder of CHO, is a board-certified medical oncologist and hematologist with extensive training and experience in the field [3] - The team at CHO includes board-certified nurse practitioners Christine Lightfoot and Courtney Nash, both of whom have been providing care in Arkansas for several years [4][5] Commitment to Care - CHO offers comprehensive community-based oncology services, including the latest diagnostic and treatment technologies, private exam rooms, an onsite laboratory, and infusion suites designed for patient comfort [6][11] - AON's mission aligns with CHO's commitment to personalized, high-quality care in a community setting, aiming to improve cancer care accessibility [7][10]

Core Points - American Oncology Network (AON) has received reaccreditation from the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida, following a recent on-site inspection [1][3] - CAP accreditation ensures laboratories operate at high levels of accuracy and reliability, contributing to improved patient outcomes and reduced clinical risk [2] - The reaccreditation reflects AON's commitment to quality standards in laboratory medicine, which plays a critical role in modern cancer care [3][4] Company Overview - AON is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology, founded in 2018, representing over 290 providers across 21 states [7] - The organization promotes innovative healthcare solutions through a physician-led model, emphasizing value-based care to improve patient outcomes while reducing costs [7] - AON is dedicated to health equity, addressing disparities in cancer care, and ensuring all patients have access to necessary care for optimal health outcomes [7]

Core Insights - American Oncology Network (AON) is expanding access to Bispecific T-cell Engager (BiTE) therapy across more than 40 partner clinics in 18 states and Washington, D.C., enhancing treatment options for hard-to-treat cancers [1][4] - Bispecific therapies represent a significant advancement in cancer treatment by engaging the immune system to target cancer cells more effectively [2][7] - AON's commitment to integrating innovative therapies like bispecific antibodies into their offerings aims to improve patient outcomes for challenging cancers [3][9] Company Overview - AON is a rapidly growing network of community oncology practices, founded in 2018, representing over 290 providers across 21 states [11] - The organization focuses on value-based care, aiming to improve patient outcomes while reducing costs and expanding access to quality care [11] - AON is dedicated to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary treatments [11] Treatment Details - Bispecific therapies work by dual targeting, engaging T cells to increase immune activity at tumor sites, and enhancing the immune response while minimizing damage to healthy tissue [7] - Since March 2025, AON has provided bispecific antibody therapy for various cancers, including acute lymphoblastic leukemia and multiple myeloma [3][4] - AON's implementation of BiTE therapies allows patients to receive advanced treatments in community settings, reducing the need for travel to major medical centers [4][9] Clinical Trials and Research - AON actively participates in clinical trials and collaborates with leading researchers to explore new applications of bispecific antibodies in oncology [8]

Core Viewpoint - Auerbach Hematology and Oncology Associates PC has joined the American Oncology Network (AON), rebranding as The Center for Cancer and Blood Disorders (CCBD)—Baltimore, to enhance patient services and expand clinical trial offerings [1][11]. Company Overview - Auerbach Hematology and Oncology Associates PC has been providing cancer care in Baltimore for 24 years and is now part of AON, which represents over 290 providers across 21 states [10][11]. - The practice specializes in the diagnosis and treatment of blood disorders and cancer, offering services such as chemotherapy, targeted therapy, immunotherapy, and clinical trials [12]. Leadership and Expertise - Dr. Michael Auerbach, Dr. Huzefa Bahrain, and Stephanie Horrocks are key figures in the practice, with extensive backgrounds in hematology and oncology [3][4][5]. - Dr. Auerbach is recognized for his expertise in iron deficiency anemia and serves as a Clinical Professor at Georgetown University [3]. - Dr. Bahrain is a key opinion leader in intravenous iron treatment and has multiple publications in the field [4]. Partnership Benefits - The partnership with AON allows CCBD to provide innovative, high-quality, and personalized cancer care while maintaining a patient-centered approach [6][9]. - The collaboration aims to enhance service delivery and improve patient outcomes through expanded offerings and resources [6][9]. Community Impact - CCBD serves patients in Baltimore, Bethesda, and Germantown, Maryland, focusing on reducing travel burdens for patients and their families [8]. - The practice features private exam rooms and on-site infusion suites to ensure patient comfort and privacy during treatment [8].

Company Overview - Florida Oncology and Hematology has expanded its Fort Myers clinic to include radiology services, enhancing cancer care for the Lee County community [1][3] - The practice operates five clinics in the region, providing personalized care plans tailored to individual patient needs [3][8] - Florida Oncology and Hematology is a partner of American Oncology Network (AON), which is one of the fastest-growing community oncology networks in the United States [4][7] Services Offered - The expanded clinic now offers PET services, 12 exam rooms for consultations, nearly 30 infusion chairs, and an on-site lab [2] - The addition of PET services allows for diagnostic PET and CT imaging, as well as innovative Radioligand Therapy for treating various cancers [5] - AON provides access to expanded services such as an in-house specialty pharmacy for home delivery of select medications [4][7] Commitment to Care - The medical director emphasizes the importance of delivering compassionate, high-quality care in a comprehensive and comfortable setting [3] - AON is committed to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary treatments [7] - The practice focuses on providing high-quality, affordable care in a supportive and accessible environment [3][8]